Optimising NOAC management in atrial fibrilllation and ACS/PCI - Clinical practice perspective
Topic:
Stroke Prevention
Speaker:
Professor R. Storey (Sheffield, GB)
Professor R. Lopes (Durham, US)
Professor S. Halvorsen (Oslo, NO)
Sponsored by The Bristol-Myers Squibb/Pfizer Alliance
Event:
ESC Congress 2019
Congress Presentation
About the speakers
Professor Robert Storey
University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)
23
presentations
1
follower
Professor Renato Lopes
Duke University Medical Center, Durham (United States of America)
21
presentations
0
follower
Professor Sigrun Halvorsen
Oslo University Hospital Ulleval, Oslo (Norway)
37
presentations
14
followers
Access the full session
Optimising non-vitamin K antagonist oral anticoagulant (NOAC) management in atrial fibrillation and acute coronary syndrome (ACS)/percutaneous coronary intervention (PCI) - Clinical practice perspective
Speakers:
Professor R. Storey, Professor R. Lopes, Professor S. Halvorsen
About the event
ESC 365 is supported by
